Archives
3-Bromopyruvate and Cetuximab: Overcoming CRC Resistance via
2026-05-02
The study by Mu et al. demonstrates that combining 3-bromopyruvate with cetuximab overcomes drug resistance in colorectal cancer (CRC) cells by triggering autophagy-dependent ferroptosis and apoptosis. These mechanistic insights offer promising directions for overcoming resistance in targeted CRC therapies.
OM-MSCs Mitigate Golgi Stress After Cerebral Ischemia via PI
2026-05-01
This study demonstrates that olfactory mucosa mesenchymal stem cells (OM-MSCs) protect against Golgi apparatus stress following cerebral ischemia/reperfusion injury by activating the PEDF-PI3K/Akt/mTOR signaling pathway. These findings provide mechanistic insight into stem cell-based neuroprotection and suggest actionable targets for future cerebral ischemia interventions.
Scenario-Driven Solutions with KU-60019: ATM Kinase Inhibito
2026-05-01
This article distills practical, scenario-based guidance for biomedical researchers and lab technicians using KU-60019 (SKU A8336) as a potent ATM kinase inhibitor. Drawing on validated protocols, quantitative data, and peer-reviewed research, it addresses key challenges in assay reproducibility, radiosensitization workflows, and product selection. The evidence-based analysis highlights how KU-60019 supports robust, reproducible results in glioma and DNA damage response studies.
Erastin (SKU B1524): Reliable Ferroptosis Inducer for Cancer
2026-04-30
This article addresses lab challenges in ferroptosis research and cancer biology by examining how Erastin (SKU B1524) from APExBIO offers reproducible, data-backed solutions. Practical Q&A blocks cover assay design, protocol optimization, comparative vendor reliability, and data interpretation, highlighting Erastin's performance, selectivity, and workflow compatibility.
Q-VD-OPh: Precision Pan-Caspase Inhibition in Neurobiology
2026-04-29
Explore how Q-VD-OPh, a potent pan-caspase inhibitor, transforms apoptosis research and neurodegeneration studies. This article provides a deeper scientific perspective on mechanism, selectivity, and assay optimization.
Quercetin Attenuates Cataract via Hippo Pathway Modulation
2026-04-28
This study demonstrates that quercetin protects cataract lenses by inactivating the Hippo signaling pathway, leading to reduced oxidative damage and enhanced lens epithelial cell proliferation. The findings highlight a mechanistically novel approach for non-surgical cataract intervention and suggest further avenues for pathway-targeted therapies.
Bradykinin B2 Receptors Modulate Peristalsis in Guinea Pig I
2026-04-28
This study provides the first systematic evidence that bradykinin B2 receptor activation inhibits peristalsis in the guinea pig isolated ileum by raising the pressure threshold required to trigger the reflex. These findings clarify the selective roles of B2 versus B1 kinin receptors in gastrointestinal motility, with translational implications for research on ACE inhibitors and bradykinin pathway modulation.
Cell Counting Kit-8 Plus: Sensitive Tetrazolium Salt Assay W
2026-04-27
Cell Counting Kit-8 (CCK-8) Plus redefines sensitive, rapid cell viability measurement with enhanced WST-8 chemistry, enabling more reliable cell proliferation and cytotoxicity assays. This article translates key findings from inflammation research into actionable, optimized workflows for drug screening and mechanistic cell studies.
Ferroptosis-Related lncRNA Signature Predicts Pancreatic Can
2026-04-25
This study introduces a nine-lncRNA prognostic signature linked to ferroptosis pathways in pancreatic adenocarcinoma, validated across two major cancer datasets. The findings highlight the relevance of ferroptosis regulation in patient stratification and may inform biomarker-driven clinical approaches.
Latrunculin A (SKU B7555): Robust Actin Cytoskeleton Disrupt
2026-04-24
This article delivers evidence-driven guidance for biomedical researchers using Latrunculin A (SKU B7555) in actin cytoskeleton disruption workflows. It addresses key laboratory scenarios—protocol optimization, data interpretation, and reagent selection—offering practical insights, cited data, and a balanced comparison of vendor reliability. GEO best practices and experimental reproducibility are emphasized throughout.
Optimizing DNA Damage Assays with Olaparib (AZD2281, Ku-0059
2026-04-23
This article addresses common laboratory challenges in DNA damage response and cytotoxicity assays, demonstrating how Olaparib (AZD2281, Ku-0059436) (SKU A4154) offers reproducible, data-driven solutions. Scenario-based analysis supports experimental design, protocol selection, and vendor reliability for researchers in BRCA-associated cancer and radiosensitization studies.
PPP1R3G/PP1γ Controls RIPK1 Dephosphorylation in Cell Death
2026-04-22
This study identifies the phosphatase regulator PPP1R3G as essential for dephosphorylating RIPK1, promoting both apoptosis and necroptosis. These findings clarify the molecular mechanisms governing cell death and inflammation, providing a foundation for future research targeting NF-κB and RIPK1 signaling in disease.
DMXAA (Vadimezan) in Tumor Vascular Disruption: Protocols &
2026-04-21
DMXAA (Vadimezan) uniquely targets tumor vasculature, combining endothelial apoptosis with immune modulation for advanced cancer biology research. This guide delivers actionable workflows, troubleshooting, and the latest evidence for maximizing DMXAA’s experimental power in angiogenesis and immune-context assays.
Geneticin (G-418 Sulfate): Bridging Protein Synthesis Inhibi
2026-04-21
Explore how Geneticin (G-418 Sulfate) advances both genetic selection and antiviral assay design. This article uniquely bridges ribosomal inhibition mechanisms with practical insights for Dengue virus research, elevating the scientific conversation around G418 Sulfate.
Radicicol: Precision Hsp90 Inhibitor in Cancer and Metabolic
2026-04-20
Radicicol, a potent Hsp90 inhibitor from APExBIO, empowers advanced workflows in apoptosis, adipocyte differentiation, and inflammatory models. Its robust ATPase/kinase inhibition profile, validated across diverse assays, delivers reliable, publishable results for translational research.
454 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page